Pharmaxi Poland sp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2022-03-24
Share capital
5,000.00 PLN
Activity description

Pharmaxi Poland is a mid-sized CRO operating in Ukraine, Poland and other European countries. It conducts phase III–IV clinical trials, postmarketing studies and registries, and provides clinical evaluation of medical devices and IVDs, alongside clinical operations, medical writing, data management and other services. The company uses its proprietary OnlineCRF EDC system and works with local vendors.

Registered address
ul. Korytnicka 46/52, 04-109 Warszawa, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-93766-73553-SJJHJ-28

Financials

Revenue history (in k)

From the notes

Profit allocationLoss covered

Filing timeliness

3 of 4 financial statements were filed late (the longest delay 660 days for 2022).

  • 202503/07/2026
  • 202428/01/2026
  • 202305/05/2025
  • 202205/05/2025
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 38%
City · Warszawa32,284 / 56,772
Top 57%
Voivodeship · Mazowieckie44,932 / 76,953
Top 58%
Country · Poland177,596 / 297,266
Top 60%

Results vs industry

Revenue
This companyUSD 152.29kMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD 2.07kMedianUSD 68.58AverageUSD 83.05k
Operating costs
This companyUSD 139.49kMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 140.30kMedianUSD 120.25kAverageUSD 3.90m

Offer

Website technology

Analytics and marketing
  • Google Tag Manager

Authorized Representatives

Iryna Hoi – Attorney-in-fact (sole)
Yurii Lebid age 45 – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
19$256.6219%
81$1,094.0081%

Yurii Lebid and Tetiana Lebid hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2022-04-18.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name
2kmm sp. z o.o.
Scientia Cro sp. z o.o.
CTI Clinical Trial and Consulting Services Poland sp. z o.o.
MDR Regulator sp. z o.o.
Genelytica sp. z o.o.
Monipol Biotech Pl sp. z o.o.
GCP-Service International Ltd. & Co. Kg Branch (foreign co.)
Quantum Satis sp. z o.o.
Medapp Clinical Research sp. z o.o.
Biostat Research and Development sp. z o.o.

Change history

DateEvent
2025-02-05Address change
2022-03-24Entered in the register

FAQ

Last updated: 2026-07-06